Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression.
Clin Cancer Res. 2023 Sep 1;29(17):3484-3497. doi: 10.1158/1078-0432.CCR-23-0749.
Clin Cancer Res. 2023.
PMID: 37410426
Free PMC article.
Activation of Receptor Tyrosine Kinases Mediates Acquired Resistance to MEK Inhibition in Malignant Peripheral Nerve Sheath Tumors.
Wang J, Pollard K, Calizo A, Pratilas CA.
Wang J, et al. Among authors: calizo a.
Cancer Res. 2021 Feb 1;81(3):747-762. doi: 10.1158/0008-5472.CAN-20-1992. Epub 2020 Nov 17.
Cancer Res. 2021.
PMID: 33203698
Free PMC article.
Item in Clipboard
Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.
Larsson AT, Bhatia H, Calizo A, Pollard K, Zhang X, Conniff E, Tibbitts JF, Rono E, Cummins K, Osum SH, Williams KB, Crampton AL, Jubenville T, Schefer D, Yang K, Lyu Y, Pino JC, Bade J, Gross JM, Lisok A, Dehner CA, Chrisinger JSA, He K, Gosline SJC, Pratilas CA, Largaespada DA, Wood DK, Hirbe AC.
Larsson AT, et al. Among authors: calizo a.
Neuro Oncol. 2023 Nov 2;25(11):2044-2057. doi: 10.1093/neuonc/noad097.
Neuro Oncol. 2023.
PMID: 37246765
Free PMC article.
Item in Clipboard
Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma.
Odeniyide P, Yohe ME, Pollard K, Vaseva AV, Calizo A, Zhang L, Rodriguez FJ, Gross JM, Allen AN, Wan X, Somwar R, Schreck KC, Kessler L, Wang J, Pratilas CA.
Odeniyide P, et al. Among authors: calizo a.
Oncogene. 2022 May;41(21):2973-2983. doi: 10.1038/s41388-022-02305-x. Epub 2022 Apr 22.
Oncogene. 2022.
PMID: 35459782
Free PMC article.
Item in Clipboard
Correction: Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma.
Odeniyide P, Yohe ME, Pollard K, Vaseva AV, Calizo A, Zhang L, Rodriguez FJ, Gross JM, Allen AN, Wan X, Somwar R, Schreck KC, Kessler L, Wang J, Pratilas CA.
Odeniyide P, et al. Among authors: calizo a.
Oncogene. 2022 May;41(21):3037. doi: 10.1038/s41388-022-02342-6.
Oncogene. 2022.
PMID: 35534540
Free PMC article.
No abstract available.
Item in Clipboard
Analysis of treatment sequence and outcomes in patients with relapsed malignant peripheral nerve sheath tumors.
Zhang L, Lemberg KM, Calizo A, Varadhan R, Siegel AH, Meyer CF, Blakeley JO, Pratilas CA.
Zhang L, et al. Among authors: calizo a.
Neurooncol Adv. 2023 Dec 2;5(1):vdad156. doi: 10.1093/noajnl/vdad156. eCollection 2023 Jan-Dec.
Neurooncol Adv. 2023.
PMID: 38130899
Free PMC article.
Item in Clipboard
CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.
Wang J, Calizo A, Zhang L, Pino JC, Lyu Y, Pollard K, Zhang X, Larsson AT, Conniff E, Llosa NJ, Wood DK, Largaespada DA, Moody SE, Gosline SJ, Hirbe AC, Pratilas CA.
Wang J, et al. Among authors: calizo a.
Sci Adv. 2023 Nov 24;9(47):eadg8876. doi: 10.1126/sciadv.adg8876. Epub 2023 Nov 24.
Sci Adv. 2023.
PMID: 38000020
Free PMC article.
Item in Clipboard
CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon restoration of RB function in malignant peripheral nerve sheath tumors.
Wang J, Calizo A, Zhang L, Pino JC, Lyu Y, Pollard K, Zhang X, Larsson AT, Conniff E, Llosa N, Wood DK, Largaespada DA, Moody SE, Gosline SJ, Hirbe AC, Pratilas CA.
Wang J, et al. Among authors: calizo a.
bioRxiv [Preprint]. 2023 Feb 3:2023.02.02.526674. doi: 10.1101/2023.02.02.526674.
bioRxiv. 2023.
PMID: 36778419
Free PMC article.
Updated.
Preprint.
Item in Clipboard
Cite
Cite